• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供应链提高疫苗可及性,带来全球效益。

Supply chains create global benefits from improved vaccine accessibility.

机构信息

Department of Computer Science and Technology, University of Cambridge, Cambridge, UK.

The World Economic Forum, Geneva, Switzerland.

出版信息

Nat Commun. 2023 Mar 21;14(1):1569. doi: 10.1038/s41467-023-37075-x.

DOI:10.1038/s41467-023-37075-x
PMID:36944651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10030081/
Abstract

Ensuring a more equitable distribution of vaccines worldwide is an effective strategy to control global pandemics and support economic recovery. We analyze the socioeconomic effects - defined as health gains, lockdown-easing effect, and supply-chain rebuilding benefit - of a set of idealized COVID-19 vaccine distribution scenarios. We find that an equitable vaccine distribution across the world would increase global economic benefits by 11.7% ($950 billion per year), compared to a scenario focusing on vaccinating the entire population within vaccine-producing countries first and then distributing vaccines to non-vaccine-producing countries. With limited doses among low-income countries, prioritizing the elderly who are at high risk of dying, together with the key front-line workforce who are at high risk of exposure is projected to be economically beneficial (e.g., 0.9%~3.4% annual GDP in India). Our results reveal how equitable distributions would cascade more protection of vaccines to people and ways to improve vaccine equity and accessibility globally through international collaboration.

摘要

确保全球疫苗更公平的分配是控制全球大流行和支持经济复苏的有效策略。我们分析了一系列理想化的 COVID-19 疫苗分配方案的社会经济影响 - 定义为健康收益、放宽封锁效应和供应链重建效益。我们发现,与专注于首先在疫苗生产国为所有人接种疫苗,然后向非疫苗生产国分发疫苗的方案相比,在全球范围内公平分配疫苗将使全球经济受益增加 11.7%(每年 9500 亿美元)。在低收入国家疫苗剂量有限的情况下,优先考虑高风险死亡的老年人以及高风险暴露的关键一线工作人员预计在经济上是有益的(例如,印度每年 GDP 的 0.9%至 3.4%)。我们的研究结果揭示了公平分配如何将更多的疫苗保护递送给人们,以及通过国际合作改善全球疫苗公平性和可及性的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/bf0edd51fdc9/41467_2023_37075_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/c1107ffd398d/41467_2023_37075_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/3d06cfbc5a51/41467_2023_37075_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/08b85dc28af1/41467_2023_37075_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/d1d93d7f8875/41467_2023_37075_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/bf0edd51fdc9/41467_2023_37075_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/c1107ffd398d/41467_2023_37075_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/3d06cfbc5a51/41467_2023_37075_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/08b85dc28af1/41467_2023_37075_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/d1d93d7f8875/41467_2023_37075_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92af/10030631/bf0edd51fdc9/41467_2023_37075_Fig5_HTML.jpg

相似文献

1
Supply chains create global benefits from improved vaccine accessibility.供应链提高疫苗可及性,带来全球效益。
Nat Commun. 2023 Mar 21;14(1):1569. doi: 10.1038/s41467-023-37075-x.
2
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.预留 2019 冠状病毒病疫苗以实现全球可及:横断面分析。
BMJ. 2020 Dec 15;371:m4750. doi: 10.1136/bmj.m4750.
3
COVAX and equitable access to COVID-19 vaccines.新冠疫苗实施计划与公平获取疫苗。
Bull World Health Organ. 2022 May 1;100(5):315-328. doi: 10.2471/BLT.21.287516. Epub 2022 Mar 25.
4
Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan.回顾《新冠疫苗分配计划中的全民健康覆盖愿景和公平性》。
Pan Afr Med J. 2021 Jul 13;39:197. doi: 10.11604/pamj.2021.39.197.29041. eCollection 2021.
5
Model-informed health and socio-economic benefits of enhancing global equity and access to Covid-19 vaccines.模型驱动的健康和社会经济效益,以增强全球公平性和获得 COVID-19 疫苗。
Sci Rep. 2023 Dec 7;13(1):21707. doi: 10.1038/s41598-023-48465-y.
6
Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?新冠病毒疫苗不平等是否正在破坏新冠大流行的复苏?
J Glob Health. 2022 May 23;12:05020. doi: 10.7189/jogh.12.05020.
7
Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach.SARS-CoV-2 疫苗可及性的决定因素:初步探讨。
Int J Equity Health. 2021 Aug 14;20(1):183. doi: 10.1186/s12939-021-01520-4.
8
The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.新冠疫苗在中低收入国家延迟接种的影响。
Front Public Health. 2023 Jan 12;10:1087138. doi: 10.3389/fpubh.2022.1087138. eCollection 2022.
9
The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.国家收入和疫苗犹豫对国家层面 COVID-19 疫苗接种率的影响。
PLoS One. 2023 Nov 2;18(11):e0293184. doi: 10.1371/journal.pone.0293184. eCollection 2023.
10
COVAX, vaccine donations and the politics of global vaccine inequity.新冠疫苗全球获取机制、疫苗捐赠与全球疫苗不平等的政治问题
Global Health. 2022 Mar 5;18(1):26. doi: 10.1186/s12992-022-00801-z.

引用本文的文献

1
Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions.加速疫苗开发的计算工具与数据整合:挑战、机遇及未来方向
Front Immunol. 2025 Mar 7;16:1502484. doi: 10.3389/fimmu.2025.1502484. eCollection 2025.
2
[We must not remain blind to equity: lessons to be learned from the COVID-19 pandemic in the AmericasDeixar de ignorar a equidade: lições a aprender com a pandemia de COVID-19 nas Américas].我们绝不能对公平问题视而不见:从美洲的新冠疫情中吸取的教训 不能忽视公平:从美洲的新冠疫情中吸取的教训
Rev Panam Salud Publica. 2024 Sep 16;48:e71. doi: 10.26633/RPSP.2024.71. eCollection 2024.
3

本文引用的文献

1
How to avoid a local epidemic becoming a global pandemic.如何避免局部疫情演变为全球大流行。
Proc Natl Acad Sci U S A. 2023 Mar 7;120(10):e2220080120. doi: 10.1073/pnas.2220080120. Epub 2023 Feb 27.
2
Optimal vaccine subsidies for endemic diseases.针对地方病的最佳疫苗补贴。
Int J Ind Organ. 2022 Sep;84:102840. doi: 10.1016/j.ijindorg.2022.102840. Epub 2022 Apr 2.
3
Lessons Learnt From the COVID-19 Pandemic.从 COVID-19 大流行中吸取的教训。
Design and management considerations for the Kenya-Tanzania marine transboundary conservation area.
肯尼亚-坦桑尼亚海洋跨界保护区的设计与管理考量
Conserv Biol. 2025 Feb;39(1):e14342. doi: 10.1111/cobi.14342. Epub 2024 Aug 6.
4
Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2.接种疫苗、国际旅行、公共卫生和社会措施与 SARS-CoV-2 谱系动态的关联。
Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2305403120. doi: 10.1073/pnas.2305403120. Epub 2023 Aug 7.
Front Public Health. 2021 Aug 2;9:694705. doi: 10.3389/fpubh.2021.694705. eCollection 2021.
4
A general model for the demographic signatures of the transition from pandemic emergence to endemicity.从大流行出现到地方病流行转变的人口统计学特征的通用模型。
Sci Adv. 2021 Aug 11;7(33). doi: 10.1126/sciadv.abf9040. Print 2021 Aug.
5
Switching vaccination among target groups to achieve improved long-lasting benefits.在目标群体中转换疫苗接种方式以实现更好的长期效益。
R Soc Open Sci. 2021 Jun 16;8(6):210292. doi: 10.1098/rsos.210292.
6
Impacts of COVID-19 outbreak on the spillovers between US and Chinese stock sectors.新冠疫情爆发对中美股市板块间溢出效应的影响。
Financ Res Lett. 2021 May;40:101922. doi: 10.1016/j.frl.2021.101922. Epub 2021 Jan 5.
7
Addressing challenges to rolling out COVID-19 vaccines in African countries.应对非洲国家推广新冠疫苗的挑战。
Lancet Glob Health. 2021 Jun;9(6):e746-e748. doi: 10.1016/S2214-109X(21)00097-8. Epub 2021 Mar 10.
8
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.确保全球公平获得 COVID-19 疫苗面临的挑战:生产、可负担性、分配和部署。
Lancet. 2021 Mar 13;397(10278):1023-1034. doi: 10.1016/S0140-6736(21)00306-8. Epub 2021 Feb 12.
9
Immunological characteristics govern the transition of COVID-19 to endemicity.免疫特性决定了 COVID-19 向地方病的转变。
Science. 2021 Feb 12;371(6530):741-745. doi: 10.1126/science.abe6522. Epub 2021 Jan 12.
10
Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.从博弈论角度激励富裕国家参与新冠疫苗全球获取机制(COVAX)
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003627.